Home/Filings/4/0001213900-23-040579
4//SEC Filing

HSU ERIC C 4

Accession 0001213900-23-040579

CIK 0001728328other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 6:00 PM ET

Size

5.4 KB

Accession

0001213900-23-040579

Insider Transaction Report

Form 4
Period: 2023-05-16
HSU ERIC C
Sr VP, Pre-Clinical Res/Dev
Transactions
  • Expiration (Short)

    Employee Stock Option (Expiration)

    2023-05-161528,181 total
    Exercise: $623.93From: 2018-05-16Exp: 2023-05-16Common shares (152 underlying)
Footnotes (1)
  • [F1]Converted from the Canadian dollar exercise price of C$841.50 using an exchange rate of C$1.3487 = $US1.00

Documents

1 file

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1
  • filerCIK 0001817867

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 6:00 PM ET
Size
5.4 KB